Elisabeth Mocaër Selected Research

N- (4- (2- (8- cyano- 1,3a,4,9b- tetrahydro(1)benzopyrano(3,4- c)pyrrol- 2(3H)- yl)ethyl)phenyl)acetamide

3/2009	The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.
2/2008	S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabeth Mocaër Research Topics

Disease

3	Mood Disorders (Mood Disorder) 03/2013 - 07/2010
2	Neuralgia (Stump Neuralgia) 01/2018 - 01/2017
2	Anhedonia 12/2011 - 03/2011
1	Hyperalgesia 01/2018
1	Cognitive Dysfunction 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Memory Disorders (Memory Loss) 01/2017
1	Major Depressive Disorder (Major Depressive Disorders) 07/2012
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2009
1	Substance-Related Disorders (Drug Abuse) 03/2009
1	Hypothermia 02/2008

Drug/Important Bio-Agent (IBA)

6	agomelatine (S20098)IBA 01/2018 - 07/2010
4	Antidepressive Agents (Antidepressants)IBA 01/2018 - 07/2010
2	MelatoninIBA 01/2018 - 01/2017
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 07/2010
2	Pharmaceutical PreparationsIBA 03/2013 - 03/2009
2	Sucrose (Saccharose)IBA 12/2011 - 03/2011
2	N- (4- (2- (8- cyano- 1,3a,4,9b- tetrahydro(1)benzopyrano(3,4- c)pyrrol- 2(3H)- yl)ethyl)phenyl)acetamideIBA 03/2009 - 02/2008
1	MT2 Melatonin ReceptorIBA 01/2018
1	6- chloro- 5- methyl- 1- ((2- (2- methylpyrid- 3- yloxy)pyrid- 5- yl)carbamoyl)indolineIBA 01/2018
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2018
1	2- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA 01/2018
1	Serotonin 5-HT2 Receptor AntagonistsIBA 01/2018
1	Serotonin AntagonistsIBA 01/2018
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2017
1	5-HT2C Serotonin ReceptorIBA 01/2017
1	Amino Acids FDA Link 07/2012
1	Melatonin Receptors (Melatonin Receptor)IBA 07/2010
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2010
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 07/2010
1	Fluoxetine (Prozac)FDA LinkGeneric 07/2010
1	Dopamine (Intropin)FDA LinkGeneric 03/2009
1	tetralinIBA 02/2008
1	hydroxide ionIBA 02/2008

Therapy/Procedure

2	Ligation 01/2018 - 01/2017
1	Self Administration (Administration, Self) 03/2009